Suppression of anchorage-independent growth by expression of the ataxia-telangiectasia group D complementing gene, ATDC

Biochemical and Biophysical Research Communications

Volumn 348, Issue 2, 2006, Pages 728-734

  Hosoi, Yoshio ^a,b   Kapp, Leon N ^b   Murnane, John P ^b   Matsumoto, Yoshihisa ^a   Enomoto, Atsushi ^a   Ono, Tetsuya ^c   Miyagawa, Kiyoshi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

11q23; ATDC; Carcinogenesis; LOH; Suppressor oncogene; Transformation

Indexed keywords

AGAR; ATAXIA TELANGIECTASIA GROUP D COMPLEMENTING PROTEIN; MESSENGER RNA; PROTEIN; UNCLASSIFIED DRUG;

ANCHORAGE INDEPENDENT GROWTH; ARTICLE; ATAXIA TELANGIECTASIA GROUP D COMPLEMENTING GENE; BREAST CANCER; CANCER CELL CULTURE; CARCINOGENESIS; COLONY FORMATION; CONTROLLED STUDY; GENE; GENE EXPRESSION; GENETIC TRANSFECTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CELL LINE, TUMOR; CELL PROLIFERATION; CELL TRANSFORMATION, VIRAL; DNA-BINDING PROTEINS; HUMANS; SIMIAN VIRUS 40; TRANSCRIPTION FACTORS; TRANSFECTION; TUMOR STEM CELL ASSAY;

ATAXIA TELANGIECTASIA;

EID: 33746923042     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.07.115     Document Type: Article

References (24)

1. Kapp L.N., Painter R.B., Yu L.C., van Loon III N., Richard C.W., James M.R., Cox D.R., and Murnane J.P. Cloning of a candidate gene for ataxia-telangiectasia group D. Am. J. Hum. Genet. 51 (1992) 45-54
2. Murnane J.P., and Kapp L.N. A critical look at the association of human genetic syndromes with sensitivity to ionizing radiation. Semin. Cancer Biol. 4 (1993) 93-104
3. Kapp L.N., and Painter R.B. Stable radioresistance in ataxia-telangiectasia cells containing DNA from normal human cells. Int. J. Radiat. Biol. 56 (1989) 667-675
4. Leonhardt E.A., Kapp L.N., Young B.R., and Murnane J.P. Nucleotide sequence analysis of a candidate gene for ataxia-telangiectasia group D (ATDC). Genomics 19 (1994) 130-136
5. Reddy B.A., Etkin L.D., and Freemont P.S. A novel zinc finger coiled-coil domain in a family of nuclear proteins. Trends Biochem. Sci. 17 (1992) 344-345
6. Borden K.L. RING fingers and B-boxes: zinc-binding protein-protein interaction domains. Biochem. Cell Biol. 76 (1998) 351-358
7. Reymond A., Meroni G., Fantozzi A., Merla G., Cairo S., Luzi L., Riganelli D., Zanaria E., Messali S., Cainarca S., Guffanti A., Minucci S., Pelicci P.G., and Ballabio A. The tripartite motif family identifies cell compartments. EMBO J. 20 (2001) 2140-2151
8. Brzoska P.M., Chen H., Zhu Y., Levin N.A., Disatnik M.H., Mochly-Rosen D., Murnane J.P., and Christman M.F. The product of the ataxia-telangiectasia group D complementing gene, ATDC, interacts with a protein kinase C substrate and inhibitor. Proc. Natl. Acad. Sci. USA 92 (1995) 7824-7828
9. Laderoute K.R., Knapp A.M., Green C.J., Sutherland R.M., and Kapp L.N. Expression of the ATDC (ataxia telangiectasia group D-complementing) gene in A431 human squamous carcinoma cells. Int. J. Cancer 66 (1996) 772-778
10. Hosoi Y., and Kapp L.N. Expression of a candidate ataxia-telangiectasia group D gene in cultured fibroblast cell lines and human tissues. Int. J. Radiat. Biol. 66 (1994) S71-S76
11. Lane D.P., and Crawford L.V. T antigen is bound to a host protein in SV40-transformed cells. Nature 278 (1979) 261-263
12. DeCaprio J.A., Ludlow J.W., Figge J., Shew J.Y., Huang C.M., Lee W.H., Marsilio E., Paucha E., and Livingston D.M. SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell 54 (1988) 275-283
13. Koreth J., Bethwaite P.B., and McGee J.O. Mutation at chromosome 11q23 in human non-familial breast cancer: a microdissection microsatellite analysis. J. Pathol. 176 (1995) 11-18
14. Nacht M., Ferguson A.T., Zhang W., Petroziello J.M., Cook B.P., Gao Y.H., Maguire S., Riley D., Coppola G., Landes G.M., Madden S.L., and Sukumar S. Combining serial analysis of gene expression and array technologies to identify genes differentially expressed in breast cancer. Cancer Res. 59 (1999) 5464-5470
15. Ernst T., Hergenhahn M., Kenzelmann M., Cohen C.D., Bonrouhi M., Weninger A., Klaren R., Grone E.F., Wiesel M., Gudemann C., Kuster J., Schott W., Staehler G., Kretzler M., Hollstein M., and Grone H.J. Decrease and gain of gene expression are equally discriminatory markers for prostate carcinoma: a gene expression analysis on total and microdissected prostate tissue. Am. J. Pathol. 160 (2002) 2169-2180
16. Murnane J.P. Inducible gene expression by DNA rearrangements in human cells. Mol. Cell. Biol. 6 (1986) 549-558
17. Takayama K., Salazar E.P., Lehmann A., Stefanini M., Thompson L.H., and Weber C.A. Defects in the DNA repair and transcription gene ERCC2 in the cancer-prone disorder xeroderma pigmentosum group D. Cancer Res. 55 (1995) 5656-5663
18. Takahashi R., Hashimoto T., Xu H.J., Hu S.X., Matsui T., Miki T., Bigo-Marshall H., Aaronson S.A., and Benedict W.F. The retinoblastoma gene functions as a growth and tumor suppressor in human bladder carcinoma cells. Proc. Natl. Acad. Sci. USA 88 (1991) 5257-5261
19. Chen Y.M., Chen P.L., Arnaiz N., Goodrich D., and Lee W.H. Expression of wild-type p53 in human A673 cells suppresses tumorigenicity but not growth rate. Oncogene 6 (1991) 1799-1805
20. Isaacs W.B., Carter B.S., and Ewing C.M. Wild-type p53 suppresses growth of human prostate cancer cells containing mutant p53 alleles. Cancer Res. 51 (1991) 4716-4720
21. Hansell E.J., Frisch S.M., Tremble P., Murnane J.P., and Werb Z. Simian virus 40 transformation alters the actin cytoskeleton, expression of matrix metalloproteinases and inhibitors of metalloproteinases, and invasive behavior of normal and ataxia-telangiectasia human skin fibroblasts. Biochem. Cell Biol. 73 (1995) 373-389
22. Comer K.A., Dennis P.A., Armstrong L., Catino J.J., Kastan M.B., and Kumar C.C. Human smooth muscle alpha-actin gene is a transcriptional target of the p53 tumor suppressor protein. Oncogene 16 (1998) 1299-1308
23. Rodriguez-Viciana P., Warne P.H., Khwaja A., Marte B.M., Pappin D., Das P., Waterfield M.D., Ridley A., and Downward J. Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras. Cell 89 (1997) 457-467
24. Tauchi H., Green C., Knapp M., Laderoute K., and Kapp L. Altered splicing of the ATDC message in ataxia telangiectasia group D cells results in the absence of a functional protein. Mutagenesis 15 (2000) 105-108